Holen Sie sich die Stockscreener-App
3.45
2.87%
-0.102
Handel nachbörslich:
3.35
-0.10
-2.90%
Schlusskurs vom Vortag:
$3.552
Offen:
$3.53
24-Stunden-Volumen:
26,071
Relative Volume:
0.50
Marktkapitalisierung:
$51.61M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.726
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
+10.22%
1M Leistung:
+1.62%
6M Leistung:
-14.39%
1J Leistung:
+169.53%
1-Tages-Spanne:
$3.3001
$3.6884
1-Wochen-Bereich:
$3.08
$3.6884
52-Wochen-Spanne:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Vergleichen Sie CPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.45 | 53.14M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Can volume confirm reversal in Cumberland Pharmaceuticals Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Why Cumberland Pharmaceuticals Inc. stock is recommended by analystsTrend Reversal & Safe Capital Allocation Plans - newser.com
What the charts say about Cumberland Pharmaceuticals Inc. todayProduct Launch & Accurate Technical Buy Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX) - MarketBeat
How to manage a losing position in Cumberland Pharmaceuticals Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - newser.com
Is Cumberland Pharmaceuticals Inc. still worth holding after the dip2025 Volatility Report & Intraday High Probability Alerts - newser.com
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S No Reason For Excitement - simplywall.st
Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight - GlobeNewswire Inc.
Published on: 2025-10-06 05:25:30 - newser.com
Will Cumberland Pharmaceuticals Inc. benefit from macro trendsTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-10-06 02:33:45 - newser.com
Should you wait for a breakout in Cumberland Pharmaceuticals Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Sentiment analysis tools applied to Cumberland Pharmaceuticals Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Tick level data insight on Cumberland Pharmaceuticals Inc. volatilityWatch List & High Accuracy Swing Entry Alerts - newser.com
How to build a dashboard for Cumberland Pharmaceuticals Inc. stock2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Cumberland Pharmaceuticals Announces Product Approval in Mexico - MarketScreener
Cumberland’s injectable ibuprofen receives approval in Mexico By Investing.com - Investing.com South Africa
Cumberland’s injectable ibuprofen receives approval in Mexico - Investing.com India
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - PR Newswire
Non-Opioid Pain Management Breakthrough: Cumberland's Injectable Ibuprofen Approved in Mexican Market - Stock Titan
Revolutionary Drug-Resistant Bacteria Fighter: Tabuk Brings Vibativ Antibiotic to Saudi Healthcare System - Stock Titan
Is Cumberland Pharmaceuticals Inc a good long term investmentEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in
What analysts say about Cumberland Pharmaceuticals Inc stockTechnical Analysis Insights & Reinvest for Maximum Compounding Returns - earlytimes.in
New Horizons in Intravenous IV Ibuprofen Market: Future - openPR.com
Published on: 2025-09-27 19:30:55 - newser.com
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):